-
Germany's dry rivers spark battle on engineering vs restoration
-
Putin visits Kuril islands claimed by Japan
-
Senators demand inquiry into conditions aboard USS Abraham Lincoln
-
Swiatek downs Svitolina to reach first WTA final of 2026
-
All Blacks' Proctor out of South Africa series, Mo'unga called up
-
Jones says Japan 'watching videos of geese' for Australia clash
-
Bangladesh quick Hasan reduces Australia to 74-4 at lunch
-
Bloodied but unbowed, defending champ Shelton reaches Montreal final
-
Seoul tech leads Asian stock gains as traders cheer US inflation
-
Wallabies make eight changes for return Japan Test
-
Farage and Count Binface go head-to-head in snap UK poll
-
Messi returns after father's death but Miami knocked out of Leagues Cup
-
Afghan students divided over smartphone ban at universities
-
Outflanked by AI, stars fade for South Korea's blind fortune-tellers
-
Japan go back to school for second Australia Test
-
Venezuela govt, opposition wrap up round of post-Maduro talks
-
Matthew McConaughey on his sweet return to the big screen
-
Five things to know about Zambia as it goes to the polls
-
President's economic record on the line as Zambia votes
-
Nakashima holds off Jodar to book first ATP Masters final in Montreal
-
3 Home Repairs You Can't Afford to Put Off
-
Grieving Messi available for Miami in Leagues Cup clash
-
Trump 'low-key' bets on economic pressure against Iran
-
Colombia enters 'final phase' of quake search as toll hits 265
-
Pitch invaders take selfies with Fernandes during Man Utd friendly
-
Father-figure Christie helps guide Kounta to European silver
-
No-stress Sabalenka won't fret over lackluster 2026 results
-
McIlroy returns to St. Jude to launch marathon PGA playoff push
-
Hometown hero Hudson-Smith basks in Euro glory
-
Guimaraes makes Arsenal debut in Como friendly
-
PSG down Aston Villa to retain UEFA Super Cup
-
Travis Kelce says wedding to Taylor Swift was 'best night of my life'
-
Trump's spokesperson Karoline Leavitt to step down
-
US stocks mostly up after data shows slightly lower inflation in July
-
'Imposing ignorance': US climate science under siege
-
Caracas protest denounces secrecy of Venezuela transition talks
-
As millions gazed in awe, a swathe of Spain plunged into darkness
-
Hudson-Smith regains Euro 400m title on home track
-
Xavi named first foreign Netherlands coach since 1978
-
Rob Reiner son denies grand jury murder charges
-
NBA triple-double king Westbrook to retire after 18 seasons
-
Spain darkens as solar eclipses races south from Arctic
-
'Trying to bury the science': US climate research under siege
-
Skies darken as solar eclipse heads south from Arctic to Spain
-
Eurovision to bar countries at war from hosting
-
Protest denounces secrecy of Venezuela transition talks
-
Italian teenager Curtis breaks 50m backstroke world record at Europeans
-
NBA's Los Angeles Lakers to be sold for reported $12.5 bn
-
New mum Sjostrom wins 50m butterfly for 18th European gold
-
Lukaku joins Turkish side Fenerbahce from Napoli
Trump 'considering' push to reclassify marijuana as less dangerous
US President Donald Trump on Monday said his administration could push to loosen federal restrictions on marijuana, reclassifying it as a less dangerous drug.
"We are considering that," Trump told reporters after he was queried whether an executive order on the issue was being discussed.
"A lot of people want to see it, the reclassification, because it leads to tremendous amounts of research that can't be done unless you reclassify, so we are looking at that very strongly."
At the federal level, marijuana is currently classified as a Schedule I substance, in the same league as drugs like heroin and LSD. The government considers these drugs to have high abuse potential without accepted use for medical treatment.
But dozens of US states already have legal medical marijuana programs, and many also have approved its recreational use.
According to a recent Washington Post report, Trump is aiming to push for a reclassification to Schedule III -- substances that are considered to have medical value and less potential for abuse.
That class includes ketamine and anabolic steroids.
Rescheduling is not legalization or decriminalization -- but easing federal restrictions could have ripple effects, including lowering barriers to pursue research, as authorizing clinical studies on Schedule I substances can require many layers of approval.
It could also have major tax implications for companies that legally grow and sell cannabis.
The US president cannot unilaterally reclassify a drug. The Post reported that Trump is expected to sign an executive order directing federal agencies to pursue reclassification.
Joe Biden's administration had previously pursued reclassification, but efforts stalled and were not completed before Trump took office in early 2025.
The US has a patchwork of state-level regulations regarding the commercial distribution, recreational possession and personal cultivation of cannabis.
In small amounts it is already legal for recreational use in 24 US states as well as Washington DC.
F.Wilson--AT